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While the distribution of RNA polymerase II (PolII) in a variety of complex genomes is correlated with gene
expression, the presence of PolII at a gene does not necessarily indicate active expression. Various patterns
of PolII binding have been described genome wide; however, whether or not PolII binds at transcriptionally
inactive sites remains uncertain. The two X chromosomes in female cells in mammals present an opportunity
to examine each of the two alleles of a given locus in both active and inactive states, depending on which X
chromosome is silenced by X chromosome inactivation. Here, we investigated PolII occupancy and
expression of the associated genes across the active (Xa) and inactive (Xi) X chromosomes in human
female cells to elucidate the relationship of gene expression and PolII binding. We find that, while PolII in
the pseudoautosomal region occupies both chromosomes at similar levels, it is significantly biased
toward the Xa throughout the rest of the chromosome. The general paucity of PolII on the Xi notwithstanding,
detectable (albeit significantly reduced) binding can be observed, especially on the evolutionarily younger
short arm of the X. PolII levels at genes that escape inactivation correlate with the levels of their expression;
however, additional PolII sites can be found at apparently silenced regions, suggesting the possibility of a
subset of genes on the Xi that are poised for expression. Consistent with this hypothesis, we show that a
high proportion of genes associated with PolII-accessible sites, while silenced in GM12878, are expressed
in other female cell lines.
INTRODUCTION
RNA polymerase II (PolII) is an essential component of the
eukaryotic transcriptional machinery. While other RNA poly-
merases transcribe non-coding genes, PolII is involved in tran-
scription of coding genes as well as non-coding RNA genes
(1,2). High-throughput ChIP-seq studies have described the
genomic distribution of PolII in a number of model organisms
(3–6). PolII localization relative to genes has been observed at
transcriptional start sites (TSSs) and is less often distributed
along the gene body, beyond the 3′ end, or can be absent all
together (7). In addition to its accumulation within actively
expressed genes, PolII has also been found at enhancers (8),
in intergenic regions (1), and at TSSs of developmentally
regulated genes that are periodically turned off and on (3–5).
Promoter regions of highly regulated genes that depend on
recruitment of PolII for their activation are often covered
with nucleosomes (9) that prevent PolII binding until chroma-
tin remodelers allow the pre-initiation complex (PIC) to
assemble (10). In contrast, constitutively transcribed genes
maintain their promoter region uncovered (11), thus allowing
permanent access to PolII. Upon gaining access to the promo-
ter, a number of steps must occur for PolII to actively engage
in transcription. The PIC assembles on the core promoter and
induces DNA unwinding, upon which PolII proceeds to a
promoter-proximal pause region. At this position, PolII
becomes phosphorylated, escapes the promoter-proximal
pause region and continues transcription (12). The frequently
observed bimodal distribution of TSS-associated PolII
signals reflects pausing and possibly also poising at the TSS,
as a result of PolII accumulation due to downstream rate-
limiting steps (7,13–16). Four general classes of genes have
been described based on the presence or absence of the
PIC at the promoter region as it relates to transcriptional
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activity: expressed genes with or without PIC detectable at the
promoter, and silenced genes with or without PIC detectable at
the promoter (17). PolII can also be observed within the bodies
of some genes, reflecting active elongation (18). In addition,
PolII peaks can be detected several kilobases downstream
from the 3′ end of some genes (1,8), likely reflecting the
lack of strong termination signals that allow the enzyme to
progress beyond the annotated end of genes (8).
High-throughput ChIP-seq and ChIP-chip technologies have
provided valuable information on the spatial and temporal
characteristics of various chromatin elements, including
PolII, throughout the diploid human genome (18,19). A
greater challenge arises when interpreting these data at loci
exhibiting allelic imbalance (20), as a number of genes
across the human genome are not equally expressed from
both alleles due to widespread cis- or trans-determined influ-
ences on transcription (21–23) and to effects such as
genomic imprinting (24), allelic exclusion (23) and, in
females, X chromosome inactivation (25,26). Similarly,
associated cis-acting regulatory elements, such as various
chromatin marks or components of the transcriptional machin-
ery, can themselves exhibit allele-specific patterns (27,28),
and thus, for these genomic loci, the information pertaining
to the two alleles must be separated. Examining the allele-
specific basis for such signals allows exploration of the
nature of cis-regulatory mechanisms on both PolII occupancy
and gene expression.
Although the majority of X-linked genes are silenced in
mammalian females due to X chromosome inactivation, at
least 10% of genes residing on the X chromosome are expressed
biallelically in all samples analyzed to date (29–32) and many
more exhibit variable expression patterns among different
females (29,33,34). It is presently unknown what factors deter-
mine the inactivation status of X-linked genes and how impor-
tant functionally or phenotypically it is for the Xi copy of a
given gene to be expressed or silenced. Nonetheless, the
evident heterogeneous patterns of gene expression from the
Xi provide an opportunity to examine the association among
genetic, genomic and/or stochastic signals that may underlie
PolII occupancy at different loci.
The facultative heterochromatin of the human Xi consists of
at least two distinct types of chromatin marked by a host of
components that distinguish them, including various histone
modifications or variants, binding proteins and XIST RNA
(35,36). While these and other chromatin features have been
investigated in the mouse and humans (35–40), none has yet
been tightly correlated with the inactivation status of individ-
ual genes. Because PolII is required for transcription, its pres-
ence or absence would appear to be better suited as a potential
indicator for silencing due to X inactivation. In mouse
embryonic stem cells, PolII exclusion occurs soon after the
induction of differentiation, which triggers expression of the
Xist gene (41) and subsequent inactivation of X-linked
genes. PolII is also eliminated from the human Barr body
(42); however, because the core of the Barr body is composed
of repetitive non-coding DNA, while genes (regardless of their
expression status) occupy the periphery (42), exclusion of
PolII from the Barr body core does not necessarily imply its
exclusion from genes.
The process of X inactivation is initiated early in develop-
ment, and the chromosome to be inactivated is selected at
random, such that the resulting female is a mosaic of cells car-
rying an Xi that is either maternally- (Xim) or paternally
derived (Xip) (25,43,44). Because such clonal mosaicism can
obscure the detection of Xi-specific features, a number of
investigations have turned either to oligoclonal lymphoblast
cell lines that deviate from random distribution and are
severely skewed toward one Xi chromosome or the other
(45,46) or to fibroblast cell lines that exhibit complete non-
random inactivation and thus contain pure populations of
cells with either Xim or Xip (29,31).
In this paper, we describe the PolII landscape on human
female X chromosomes utilizing PolII ChIP-seq data for the
GM12878 cell line, a chromosomally normal female lympho-
blast line. We selected this cell line because of the opportunity
to build on a number of earlier studies that have characterized
GM12878 as part of the ENCODE Project and the 1000
Genomes Project (19,47) (Reddy TE, Gertz J, Pauli F,
Newberry K, Kucera KS, Wold B, Willard HF, Myers RM,
manuscript in preparation). Because of the severe
X-inactivation skewing in GM12878 (27), we were able to
infer the enrichment of individual alleles on the Xi and Xa
and thus analyze these data in an allele-specific manner to
compare PolII distribution on the two Xs. Further, for the
purpose of elucidating the relationship of PolII-binding and
inactivation status of genes, we have focused specifically on
PolII sites that could be assigned to particular genes and,
where possible, we have determined their inactivation status
in homogeneous GM12878 Xip- and Xim-derived cell lines.
RESULTS
The human X chromosome is relatively PolII poor
We first sought to measure genomic occupancy of PolII on the
X chromosome. To do so, we used a genome-wide ChIP-seq
approach and, in two replicate samples, detected an average
of 168 sites of PolII enrichment on the X chromosomes in
the GM12878 cell line (Table 1). Notably, this reflects a sig-
nificantly (P,0.001, t-test) lower PolII peak occurrence rela-
tive to gene density on the X chromosome compared with
autosomes (Fig. 1A). We observed a similar, albeit less
extreme, situation for chromosome 11 (P,0.05, t-test) that
can likely be attributed to the fact that more than 300 olfactory
receptor genes are located on chromosome 11 (48). These
genes are not expressed in lymphoblasts, including the
Epstein–Barr virus (EBV)-immortalized GM12878 line and
make up a substantial proportion of all chromosome 11 genes.
The paucity of PolII-binding sites on the X could reflect the
number of genes, the number of expressed genes or the fre-
quency of binding as a function of chromosome size. To
explore these differences further, we compared the abundance
of PolII peaks to chromosome length (Fig. 1B) and to the
number of expressed genes for each chromosome in
GM12878 (Reddy TE, Gertz J, Pauli F, Newberry K, Kucera
KS, Wold B, Willard HF, Myers RM, manuscript in prep-
aration) (Fig. 1C). While PolII binding is loosely correlated
with chromosome length (Fig. 1B), it is better correlated
with overall gene density (Fig. 1A) and is particularly well
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correlated with the number of genes expressed in GM12878
(Fig. 1C). Thus, the relative scarcity of PolII peaks on the X
chromosome can be at least partially explained by the lower
proportion of genes that are expressed from the X chromo-
some in the GM12878 cell line when compared with
autosomes (Fig. 1).
PolII binding is biased toward the active X chromosome
In a previous study (27), we reported 92% skewing of X inac-
tivation in the GM12878 cell line toward the Xip. Because
X-inactivation skewing can drift in cell culture over time
(45,46), we verified the extent of skewing in GM12878 in
RNA samples harvested concurrently with the PolII
ChIP-seq samples generated for this study. We detected 95%
(SD ¼ 1%) skewing in the same direction as previously
described (27), by testing allele-specific expression at XIST
(rs1620574) and EBP (rs3048) by SNaPshot assays (29).
To determine whether PolII binding on the X chromosome
is influenced by X-chromosome inactivation, we focused on
the subset of individual PolII sites that contain heterozygous
single-nucleotide polymorphisms (SNPs) (Supplementary
Material, Table S1) and employed an allele-specific alignment
approach to distinguish binding on the Xa and Xi chromo-
somes. We identified 385 heterozygous SNPs (Table 1) that
had at least five mapped reads on at least one of the two X
chromosomes in the PolII ChIP-seq data set (Supplementary
Material, Table S2, Fig. 2). We chose this threshold to limit
artifacts due to spurious alignment or non-specific immuno-
precipitation of DNA. This allele-specific data set of 385
sites forms the basis for the analysis in this section.
PolII binding in the pseudoautosomal region on the distal
short arm (PAR1) is especially dense when compared with
the non-pseudoautosomal region (Fig. 2A). Furthermore, as
expected, we observed no clear bias in occupancy toward
Xa or Xi in PAR1, with 47% of the total PolII reads that
mapped to the PAR1 aligning to the Xi alleles. A few individ-
ual heterozygous PolII-binding sites showed significant bias
towards one or the other X (Fig. 2), and these likely represent
occasional allele-specific bias similar to that seen throughout
the genome (Reddy TE, Gertz J, Pauli F, Newberry K,
Kucera KS, Wold B, Willard HF, Myers RM, manuscript in
preparation, 27). It remains unknown what significance these
PolII sites have and whether they are functionally associated
with the neighboring genes.
The remaining majority of PolII sites at heterozygous pos-
itions on the X were located in the non-pseudoautosomal
region of the X chromosome. Two noteworthy observations
indicate relative depletion of PolII across the non-
pseudoautosomal portion of the Xi. First, considering this
region as a whole, we detected about five times more total
ChIP-seq reads mapping to the Xa than to Xi in this region (Sup-
plementary Material, Table S2), consistent with reduced PolII
binding being associated with X inactivation. Secondly, of the
268 non-pseudoautosomal PolII sites examined, 39% exhibited
significant bias (P,0.01, binomial test) in PolII occupancy
toward one chromosome or the other (Fig. 2B, Supplementary
Material, Table S2). Among these, all but two showed bias
toward the Xa allele. Not unexpectedly, the two sites with
Figure 1. PolII peaks per chromosome. Each human chromosome is rep-
resented by a circle (autosomes) or an open diamond (X chromosome).
Linear regression (solid line) and 97% confidence interval (dashed lines) are
shown. Number of PolII peaks is shown relative to (A) RefSeq genes;
(B) chromosome length; and (C) expressed genes in GM12878 (expression
data from Reddy TE, Gertz J, Pauli F, Newberry K, Kucera KS, Wold B,
Willard HF, Myers RM, manuscript in preparation).






TSS +500 bp 120 37
Intragenic 138 257
Extragenic 30 128
,5 kb from genes 9 60
5–30 kb from genes 15 17
.30 kb from genes 6 51
aNon-allele-specific PolII peaks called by Quest software (64) as a composite of
the two X chromosomes.
bPolII occupancy at heterozygous sites; sites with minimum of five reads at one
or the other allele were considered.
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significant PolII-binding bias toward the Xi were located in the
XIST gene (Fig. 3) (49,50). At a PolII site near the 5′ end of
XIST, 23 of the 24 sequences (96%) aligned to the paternally
derived (Xi) allele, which correlates well with the extent of
X-inactivation skewing in the cell line and implies absence of
PolII from the XIST allele on the Xa. As PolII is completely
depleted from the Xa near theXIST TSS, the relative abundance
of PolII at this site is an expression-independent indicator of
X-inactivation skewing.
The observed PolII profile on Xa and Xi (Fig. 2) appears to
reflect in part the evolutionary origins of the X chromosome,
as the bias is nearly complete in the portion of the X that
corresponds to the ancestral conserved region of the X
chromosome (XCR), but is decidedly less extreme in the
Figure 3. Xi bias of PolII enrichment at the XIST gene. (A) PolII ChIP-seq enrichment throughout the gene is shown with the highest enrichment near the TSS.
Locations and rs numbers of heterozygous SNPs in GM12878 are indicated. (B) Relative PolII occupancy on the two X chromosomes in GM12878, as measured
by the number of aligned ChIP-seq reads at each heterozygous SNP, mapping to the Xp (white bars) or Xm (black bars). The aggregated signal from the XIST
locus is shown on the far right, indicating significant PolII binding bias toward Xp, consistent with the reported (28) and measured (see Materials and Methods)
X-inactivation bias in this cell line.
Figure 2. Allele-specific PolII occupancy on the X chromosome in GM12878. (A) Distribution of heterozygous sites with at least 10 mapped PolII ChIP-seq
reads on the X chromosome, displayed as the proportion of sites on the Xi. XAR, X-added region; XCR, X-conserved region; PAR, pseudoautosomal region.
(B) PolII occupancy on the Xm versus Xp chromosomes. Dashed axes represent 95% skewing (i.e. monoallelic occupancy) observed in the GM12878 cell line.
Solid diagonal represents equal PolII occupancy on Xi and Xa.
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portion of the X that was added more recently during evolution
(XAR) (51–53). PolII occupancy also mirrors the reported
patterns of X inactivation, as a much greater proportion of
genes in XAR escape inactivation than in XCR (29) and
thus might be expected to be associated with PolII on both
Xa and Xi.
PolII binding on the inactive X chromosome largely
mimics inactivation status of genes
Although PolII is generally depleted from the human Xi, many
sites deviate from the predicted level of X-inactivation
skewing (Fig. 2, Supplementary Material, Table S2). In the
non-pseudoautosomal region of the X chromosome, 45%
of the informative PolII-binding sites showed .10% PolII
occupancy on the Xi relative to the Xa, suggesting at least
some PolII located on the Xi alleles. Strikingly, at 12% of
sites, the level of Xi PolII occupancy exceeded 50% of the
PolII levels on Xa. Genes with high PolII occupancy on the
Xi were of special interest for considering relative gene
expression from Xi and Xa, as they could reflect either bialle-
lic expression or the presence of PolII at silenced genes.
To assess the relationship of PolII binding and gene
expression from the Xi, we combined PolII ChIP-seq signal
across each annotated gene and its flanking regions (30 kb
upstream and 5 kb downstream), considering only those sites
that could be unambiguously associated with assayable
genes (Supplementary Material, Table S3). While sites
upstream from TSSs seem likely to reflect association at regu-
latory regions for those genes (8) and downstream sites likely
result from PolII progression beyond the 3′ end (1,8), we
cannot rule out the possibility that, given the currently incom-
plete state of genome annotation, there is actually no func-
tional association of these sites with the assigned genes.
We identified 31 genes with robust and informative PolII
binding across the X chromosome (including PAR1), that is,
genes containing expressed heterozygous SNPs that could be
studied with allele-specific expression assays (Table 2). We
assayed allele-specific expression at these 31 genes in a
series of apparently clonal cell lines derived from GM12878
that were homogeneous with respect to the Xip or Xim inactive
X chromosomes (Supplementary Material, Table S3). All
seven pseudoautosomal genes, as expected, exhibited biallelic
expression, with mostly similar levels of expression from both
alleles corresponding to the PolII occupancy detected at the
associated heterozygous-binding sites (Fig. 4A). We noted
two pseudoautosomal genes IL3RA and CD99 that were rela-
tively less expressed from the paternally derived copy, regard-
less of the Xi origin (Supplementary Material, Table S3),
which may reflect either a parent-of-origin effect or imbalance
due to the particular allelic variants in these genes; further
studies in other cell lines would be required to distinguish
these possibilities. This situation is not unprecedented on the
X chromosome, as such allelic imbalance has been described
at the SYBL1 locus in PAR2 (54).
We detected several patterns of expression among the
remaining 24 tested genes located on the non-
Table 2. Relationship of expression and PolII occupancy




Monoallelic Xa 17 8a/17
Monoallelic Xi 1 1/1
Biallelic 5 5/5
Variable 1 0/1
aPolII at Xi associated with monoallelically expressed loci is defined as at least
three reads mapping to Xi and .15% of Xa PolII occupancy.
Figure 4. Expression of genes genomically associated with PolII-occupied
heterozygous sites. (A) Allele-specific binding of PolII sites associated with
biallelically expressed genes (as designated in the key). (B) Allele-specific
binding of PolII sites associated with monoallelically expressed or variable
genes (as designated in the key). Dashed axes and diagonal axis are as in
Figure 2.
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pseudoautosomal portion of the X chromosome (Table 2). As
expected, the majority (75%) of the tested genes were
expressed monoallelically in both types of Xi isolates (all
expressed exclusively from the Xa allele, other than XIST,
which was expressed only from the Xi). In addition, five
genes (21%) escaped inactivation at varying levels of
expression, and one gene (SEPT6) exhibited variable
expression between the two types of isolates.
When the gene expression profiles were related back to the
individual PolII-occupied heterozygous sites (allele-specific
data set of 385 PolII sites) (Fig. 4, Supplementary Material,
Table S2), as well as to per-gene PolII occupancy (Fig. 5, Sup-
plementary Material, Table S3), gene silencing on the Xi was
found to correlate with PolII depletion at most sites. However,
several regions on the Xip showed PolII binding well above
the expected 5% level corresponding to the X-inactivation
skewing ratio. The relationship of PolII binding at a specific
site to a particular gene is difficult to establish, especially
for sites located in intergenic regions; nevertheless, it
appears that PolII can bind at low levels even in regions
where silenced genes reside, indicating higher accessibility
of the transcriptional machinery to the Xi than previously
thought.
Among the five biallelically expressed genes, Xi expression
ranged from 5 to 98% relative to levels detected from the Xa
allele (Table 3), showing strong correlation with levels of
PolII occupancy at sites associated with those genes
(R2¼0.9) (Fig. 5). In addition, the levels of expression for
these five genes are consistent in the derivative cell lines con-
taining the two different Xi chromosomes (Xip and Xim), as
well as in duplicate lines that were cultured separately for
several weeks, indicating that the regulation of expression
levels of these genes is largely constant and thus presumably
reflects stability of the epigenomic environment of the
alleles being compared.
Our analysis of gene expression is limited by the occurrence
of transcribed heterozygous SNPs in the cell line under study.
Nonetheless, there were a number of PolII sites associated
with genes that lacked expressed SNPs, some of which have
been studied previously and thus allow for some interpret-
ation. For example, the TIMM17B and RBM3 genes are inac-
tivated in multiple human cell lines (29), which is in
agreement with the 95% Xa PolII occupancy in this study,
suggesting that both genes are also inactivated in GM12878.
In contrast, the UBA1 gene contains three heterozygous
PolII sites within its gene body, and, in the aggregate, 33%
of reads at these sites map to the Xi allele. This finding is
consistent with previous reports that UBA1 escapes inacti-
vation in all samples tested thus far (29,30,55).
PolII occupancy indicates chromatin accessibility
and potential for expression
As described above, PolII binding at genes that are not being
actively transcribed indicates a level of openness of the local
chromatin environment. We hypothesized that such genes
have the potential to be expressed in other cell lines either con-
sistently or variably with respect to the population. To test this
hypothesis, we generated Xi-homogeneous cell populations
from seven additional HapMap CEU cell lines (56,57) and
tested expression of 11 genes that were informative for
study in these cell lines, 4 genes that were expressed bialleli-
cally in GM12878 and 7 that were silenced in GM12878 yet
showed significant PolII levels at the Xi allele (Table 2).
In the case of the four genes that are biallelically expressed
in GM12878, we confirmed biallelic expression of PRKX,
TXLNG and USP9X in all informative female lines tested,
indicating that all three genes consistently escape inactivation
(Fig. 6). Furthermore, the relative levels of Xi expression of
these three genes observed in GM12878 (Table 3) are recapi-
tulated in the additional cell lines, with PRKX exhibiting
highest Xi expression (85% of Xa levels), TXLNG inter-
mediate (35% of Xa) and USP9X lowest expression
(20% of Xa). In contrast, SYN1 is a gene with variable


























Figure 5. Relationship of PolII levels and gene expression on the inactive X
chromosome in GM12878. The relationship of paternal PolII occupancy and
Xip gene expression is shown as a percentage of Xa. The diagonal axis rep-
resents direct relationship between relative PolII occupancy and expression.
Human Molecular Genetics, 2011, Vol. 20, No. 20 3969
 at M







expression from the Xi. It escapes inactivation in GM12878 at
a very low level, but is expressed robustly from Xi in another
female cell line and is completely silenced in three other
females (Fig. 6).
Of the seven silenced genes associated with PolII in
GM12878 (Table 2), we show that three (ERCC6L, GPR174
and TRAPPC2) are expressed from the Xi in other female
cell lines (Fig. 6), and one additional gene (ZNF41) has
been reported to escape inactivation previously in at least
one female cell line (29). Combined, these data demonstrate
that PolII not only binds to the Xi, but also can become
engaged and produce a transcript in some individuals.
DISCUSSION
In this study, we have examined the profile of PolII binding on
human female X chromosomes. Overall, the frequency of
PolII binding on the X chromosome and chromosome 11 is
reduced compared with other chromosomes, largely because
of the lower proportion of expressed genes in the GM12878
EBV-immortalized lymphoblastoid cell line (Fig. 1). Although
the low proportion of genes expressed from the X chromo-
some relative to autosomes largely explains the reduced fre-
quency of PolII binding, other factors will have to be
explored to explain this phenomenon fully. As is evident
here, many X-linked genes are not expressed in lymphoblas-
toid cell lines. These genes might have inactivation profiles
relevant to tissue-specific diseases that cannot therefore be
addressed in blood-derived cell lines and will have to be
explored in other types of cells.
Although overall PolII binding is reduced across the non-
pseudoautosomal region of the X chromosome (Fig. 2), the
evolutionarily younger XAR spanning most of the Xp arm
exhibits higher PolII occupancy than does the Xq arm. This
is consistent with the previously documented higher occur-
rence of genes that escape X inactivation and are expressed
from the human Xi in the XAR (29). Here we present
another piece of evidence that X inactivation is influenced
by the evolutionary origins of the underlying sequences and
show that PolII binds more readily at formerly autosomal
sequences that were introduced to the X-inactivation system
more recently (51–53,58).
Our allele-specific analysis of PolII binding has identified
five novel biallelically expressed X-linked genes (Table 3
and Supplementary Material, Table S3), some of which had
been hypothesized previously to escape inactivation in
studies performed in somatic cell hybrids or on the basis
of male/female dosage comparisons (59). For three of
these, we were able to verify biallelic expression in multiple
individuals (Fig. 6). The proportion of biallelically expressed
genes in GM12878 (21%) is consistent with previous esti-
mates of proportion of genes escaping inactivation in the
population (29). Also consistent with previous observations
is that all five of the biallelically expressed genes are
located on Xp, where escape from inactivation occurs more
frequently than on Xq (29). Our allele-specific analysis of
these five genes expressed from the Xi suggests that,
although the phosphorylated form of PolII may be a more
precise indicator for expression levels (18), the unphosphory-
lated PolII queried in our study (see Materials and Methods)
is a suitable indicator of inactivation status of genes and rela-
tive gene expression levels.
Because CpG methylation and heterochromatin markers
have been associated with X-inactivation patterns (35–40),
it was of interest to compare our expression and PolII data
with other chromatin and genomic features of the X publicly
Figure 6. Xi gene expression in multiple cell lines. Genes associated with
PolII in GM12878 (shown on vertical axis) were tested for expression in
GM12878 (open symbols) and additional heterozygous cell lines (closed
circles). Error bars represent standard deviation of the mean between biologi-
cal replicates. Expression of ZNF41 has been tested previously in ten human
cell lines (29). It was subject to inactivation in nine informative cell lines (not
shown in the figure) and escaped inactivation in one cell line (designated by an
asterisk).
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available through the ENCODE database (http://genome.ucsc.
edu/ENCODE/). We failed to detect significant association of
any particular class of genes with chromatin or genomic fea-
tures, such as presence of CpG islands or CCCTC-binding
factor binding. We did, however, note a slight increase in
association of PolII with H3K27me3 in gene bodies, indicating
a potential role that this modification could play in marking
particular Xi genes for expression in the portions of the Xi
that are enriched for this heterochromatin mark. It has been
speculated previously that H3K27me3-marked heterochroma-
tin might be less effective at silencing gene expression than
is H3K9me3-marked heterochromatin (35,36,60). To facilitate
our understanding of X chromosome inactivation, further
studies of multiple human females could take advantage of
the vast data sets that are being generated by the ENCODE
(19) and Human Epigenome (61) Projects. In combination
with 1000 Genomes Project (47), future studies will be able
to distinguishing features of the two homologous chromo-
somes in each individual to understand, for example, the
role of H3K9me3 and H3K27me3 as well as many other
histone modifications and chromatin features potentially
implicated in X chromosome inactivation.
We detected increased PolII levels at several sites along the
Xi, indicating a potential for expression despite the apparent
association with silenced loci in this cell line. In each case,
the Xa homologue was actively transcribed, while there was
no detectable transcription product from the Xi. PolII occu-
pancy at the Xi allele was particularly striking at the
TRAPPC2 gene, where 67% of PolII reads aggregated across
the locus mapped to the transcriptionally silenced Xi allele.
We hypothesized that TRAPPC2 might be expressed in
GM12878 in an unstable and inconsistent manner, and,
indeed, testing additional clones derived from GM12878
revealed that TRAPPC2 is in fact occasionally transcribed
from the Xi chromosome (Supplementary Material, Fig. S1).
In addition, TRAPPC2 clearly escapes inactivation in cell
lines from other informative females (Fig. 6); thus it is appar-
ent that the presence of a PolII signal at the TRAPPC2 locus is
indeed associated with the potential for expression.
While the finding of sites of PolII occupancy on the Xi near
genes that are subject to inactivation may appear surprising,
the large number of previously identified genes with variable
expression patterns (29,31,33,34) is consistent with the idea
that some genes on the Xi are poised for transcription in
some individuals and/or cell lineages. Sites with increased
PolII binding on the Xi identified in our study were candidate
loci for variable expression patterns and indeed, when assayed
in additional informative cell lines, we found that a high pro-
portion of genes with Xi PolII association are occasionally
expressed from the Xi in the population (Fig. 6).
Most genes that are expressed from the Xi generate RNA
output that is reduced relative to the Xa (29), an indication
that, although expression is generally suppressed chromosome-
wide, the Xi is permissive to the transcriptional machinery.
However, it remains unclear whether these low expression
levels result from leakiness of the inactive state, with little
or no phenotypic consequence in the context of full expression
from the Xa copy, or, more provocatively, they reflect, at least
in some cases, purposeful turning on the Xi allele to finely
tune the overall genetic output. It is likely that there are
numerous gene-specific control mechanisms among the
1200 genes on the X, superimposed upon the chromosome-
wide and/or regional landscapes anticipated by the process of
X inactivation. Indeed, the contrast in patterns of PolII distri-
bution and gene expression between the XAR and XCR point
to the interplay of evolutionary, genomic and local effects that
remain to be fully explored in this context.
MATERIALS AND METHODS
Cell culture and single-cell cloning
GM12878 and other cell lines were grown in a humidified
incubator at 378C and 5% CO2 in RPMI1640 media sup-
plemented with 15% fetal bovine serum and 1% antibiotics
according to the ENCODE protocol (27). For single-cell
cloning, cells were diluted in 50% conditioned media in a
series of dilutions and seeded in 96-well plates. Cells were
grown in 50% conditioned media until expansion and fed
fresh media thereafter. To prepare conditioned media, cells
were grown in fresh media over night and subsequently
removed by centrifugation and filtration; the resulting cell-free
conditioned media were diluted 1:1 with fresh media to obtain
50% conditioned media. For each presumptive clone, three
biological replicates were grown (two for RNA and one for
DNA). To confirm homogeneity of each candidate clone
with respect to X inactivation, we tested allele-specific
expression in monoallelically expressed genes, including
XIST (rs1620574) and EBP (rs3048) (29). We further verified
the purity of each selected isolate after expansion by the same
method. Two confirmed isolates of each type (100% Xim and
100% Xip) were chosen for this study. Additional isolates
derived from GM12878 were selected for further TRAPPC2
expression experiments. Isolates from seven additional
female cell lines selected from the HapMap CEU population
(GM06991, GM10861, GM10831, GM10839, GM12753,
GM12802, GM12815) were derived in the same manner.
Homogeneity with respect to the Xi was tested as described
above in addition to a second XIST SNP (rs1794213) and
FHL1 (rs1918), a gene known to be expressed solely from
the Xa and not the Xi (29).
ChIP-seq
PolII ChIP was performed on GM12878 cells, and Illumina-
based sequencing was carried out as described previously
(62,63) with minor modifications. GM12878 cells were fixed,
lysed and nuclei were collected. After lysing nuclei, chromatin
was sonicated and immunoprecipitated with 8WG16 antibody
to PolII (Covance, MMS-126R). Afterward, protein:DNA
crosslinks were reversed overnight at 658C, and DNA was iso-
lated using a Qiagen polymerase chain reaction (PCR) Cleanup
column. DNA was prepared for sequencing on an Illumina
Genome Analyzer as described previously, modified to elimin-
ate PCR prior to size selection and to use 15 cycles of PCR
after size selection. Libraries were then sequenced to a
minimum depth of 12 million 36-nucleotide reads per biologi-
cal replicate. We employed the peak-calling algorithm QuEST
(64) to detect sites of enrichment in the genome.
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Measuring allele-specific PolII occupancy
To map allele-specific occupancy of PolII sites, we con-
structed a GM12878 parent-specific version of the human
reference genome (hg18), as described previously (Reddy
TE, Gertz J, Pauli F, Newberry K, Kucera KS, Wold B,
Willard HF, Myers, RM, manuscript in preparation). We
aligned ChIP-seq reads to the modified reference genome
using the Bowtie aligner (65) and removed any alignments
that mismatched at a known heterozygous SNP position.
To detect allelic bias of PolII occupancy at each SNP, we
counted the number of reads mapping specifically to a paternal
or maternal allele at all heterozygous positions and calculated
a P-value according to a binomial model that assumes equal
likelihood of each allele.
SNaPshot
A quantitative Q-SNaPshot assay was employed to test the
abundance of each allele in the PCR amplicon, using protocols
as described previously (29,36). Briefly, DNA was isolated
from fresh cells using a Qiagen Gentra Puregene Cell Kit
and stored at 2208C. RNA was isolated from fresh cells
with a PerfectPure RNA Tissue Kit (5Prime), treated with
DNase I (Roche) and stored frozen at 2808C. Quality and
concentration of each nucleic acid sample was verified by
NanoDrop spectrophotometer and gel electrophoresis.
Random primed cDNA was synthesized from 200 to 300 ng
of RNA using iScript cDNA synthesis kit (BioRad). In each
assay, DNA and cDNA were amplified by a standard 25 ml
protocol using Taq DNA Polymerase (Invitrogen). PCR pro-
ducts were then purified (EdgeBio). A third primer was used
for the Q-SNaPshot single-nucleotide extension assay with
subsequent ABI 3100 sequencer detection. The cDNA
readout was normalized to the DNA signal with known 1:1
ratio of the two alleles to correct for biases in fluorescence
output.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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